TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

MiMedx Group Inc (NASDAQ:MDXG) Investor Investigation Over Potential Wrongdoing Announced

  • If you purchased shares of MiMedx Group Inc (NASDAQ:MDXG), you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
MiMedx Group Inc
Security
NASDAQ: MDXG

Summary

August 25, 2017 (Shareholders Foundation) - An investigation for investors in NASDAQ:MDXG shares was announced concerning possible breaches of fiduciary duties by certain directors.

The investigation by a law firm concerns whether certain MiMedx Group directors breached their fiduciary duties and caused damage to the company and its shareholders.

Marietta, GA based MiMedx Group, Inc. is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone

MiMedx Group Inc reported that its annual Total Revenue rose from $187.30 million in 2015 to $245.01 million in 2016 and that its Net Income declined from $29.45 million in 2105 to $11.97 million in 2016.

Shares of MiMedx Group Inc (NASDAQ:MDXG) grew from $6.74 per share in May 2016 to as high as $17.36 per share on August 16, 2017

Start Monitoring Your Investments